
Calumet, Inc. (NASDAQ:CLMT – Free Report) – HC Wainwright increased their FY2025 earnings per share (EPS) estimates for Calumet in a note issued to investors on Monday, November 10th. HC Wainwright analyst A. Dayal now forecasts that the oil and gas company will post earnings per share of ($3.45) for the year, up from their previous forecast of ($3.89). HC Wainwright has a “Buy” rating and a $33.00 price objective on the stock. The consensus estimate for Calumet’s current full-year earnings is ($3.02) per share. HC Wainwright also issued estimates for Calumet’s Q4 2025 earnings at ($0.50) EPS, FY2026 earnings at ($1.22) EPS, FY2027 earnings at $0.23 EPS, FY2028 earnings at $1.35 EPS and FY2029 earnings at $2.49 EPS.
Other equities analysts have also issued reports about the company. Weiss Ratings reiterated a “sell (e+)” rating on shares of Calumet in a research note on Wednesday, October 8th. Zacks Research raised Calumet from a “strong sell” rating to a “hold” rating in a report on Thursday, November 6th. UBS Group upped their price target on Calumet from $12.00 to $13.25 and gave the stock a “neutral” rating in a report on Tuesday, August 12th. TD Cowen raised their price objective on shares of Calumet from $15.00 to $18.00 and gave the stock a “hold” rating in a research note on Tuesday. Finally, The Goldman Sachs Group boosted their target price on shares of Calumet from $15.00 to $20.00 and gave the stock a “buy” rating in a research report on Wednesday, October 22nd. Four investment analysts have rated the stock with a Buy rating, three have issued a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, the stock has an average rating of “Hold” and an average price target of $20.04.
Calumet Price Performance
Calumet stock opened at $19.28 on Wednesday. Calumet has a fifty-two week low of $7.68 and a fifty-two week high of $23.75. The firm has a fifty day moving average price of $18.67 and a two-hundred day moving average price of $16.15. The firm has a market cap of $1.67 billion, a price-to-earnings ratio of -3.69 and a beta of 1.09.
Calumet (NASDAQ:CLMT – Get Free Report) last posted its quarterly earnings data on Friday, November 7th. The oil and gas company reported ($0.21) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.30) by $0.09. The firm had revenue of $1.08 billion for the quarter, compared to the consensus estimate of $1.06 billion. During the same period in the prior year, the company posted ($1.18) earnings per share. Calumet’s quarterly revenue was down 2.0% on a year-over-year basis.
Hedge Funds Weigh In On Calumet
Several hedge funds and other institutional investors have recently modified their holdings of the stock. Goldman Sachs Group Inc. lifted its holdings in shares of Calumet by 33.5% during the first quarter. Goldman Sachs Group Inc. now owns 465,269 shares of the oil and gas company’s stock valued at $5,900,000 after acquiring an additional 116,777 shares during the period. Adams Asset Advisors LLC grew its holdings in shares of Calumet by 0.9% in the 2nd quarter. Adams Asset Advisors LLC now owns 5,406,271 shares of the oil and gas company’s stock worth $85,176,000 after purchasing an additional 49,948 shares during the last quarter. Caldwell Sutter Capital Inc. increased its position in shares of Calumet by 29.9% during the 2nd quarter. Caldwell Sutter Capital Inc. now owns 19,483 shares of the oil and gas company’s stock worth $307,000 after purchasing an additional 4,483 shares in the last quarter. Wasserstein Debt Opportunities Management L.P. lifted its holdings in Calumet by 3.2% during the 2nd quarter. Wasserstein Debt Opportunities Management L.P. now owns 5,817,012 shares of the oil and gas company’s stock valued at $91,647,000 after purchasing an additional 180,197 shares during the last quarter. Finally, O Keefe Stevens Advisory Inc. boosted its position in Calumet by 12.1% in the second quarter. O Keefe Stevens Advisory Inc. now owns 26,817 shares of the oil and gas company’s stock valued at $423,000 after buying an additional 2,903 shares in the last quarter. Institutional investors own 34.41% of the company’s stock.
Calumet Company Profile
Calumet, Inc engages in the manufacturing, formulating, and marketing of a diversified slate of specialty branded products and renewable fuels to customers across a broad range of consumer-facing and industrial markets. It operates through the following segments: Specialty Products & Solutions, Performance Brands, Montana/Renewables, and Corporate.
Featured Stories
- Five stocks we like better than Calumet
- What is Forex and How Does it Work?
- 3 Beaten-Down Stocks With Rebound Potential This Earnings Season
- Pros And Cons Of Monthly Dividend Stocks
- Amazon Is One of the Clearest Buys If the Market Dips Again
- Do ETFs Pay Dividends? What You Need to Know
- CoreWeave’s Guidance Cut: A Buying Opportunity in Disguise?
Receive News & Ratings for Calumet Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Calumet and related companies with MarketBeat.com's FREE daily email newsletter.
